Eric Chen
Founder & Chief Commercial Officer, Vitargent (International) Biotechnology Limited
Mr. Eric Chen is the First Ever Forbes Asia “30 under 30” Winner (2016).
Upset by the 2008 melamine milk powder scandal on the mainland, Mr. Eric Chen established Vitargent on 2011, determined to build an innovative and efficient platform to test and certify the safety of food, drink and cosmetics. He successfully assembled an international management team, raised rounds of VCs funding and signed up with the world’s largest cosmetics groups, F&B conglomerates, leading testing labs and government departments.
A results-oriented person, Eric’s two main goals for Vitargent are to make its technology a standard for companies around the world, and to create a go-to source and portal for safe products.
Mr Chen is passionate about commercializing innovations. He invests and advices on a number of international tech companies and VC Funds including iNetwork Ltd (Israel-Focused VC fund), WI Harper (Silicon Valley VC fund), Pebbles Interface (an Israel VR company, acquired by Facebook in 2015), Taurx pharmaceuticals (Singapore), Aslan Sanguine Biosciences (Singapore) and Geneformics (Israel).
He graduated from the City University of Hong Kong with a first class degree in Engineering and minor in Marketing, and earned his Master of Economics at the University of Hong Kong. Mr. Chen is the First Ever Forbes Asia “30 under 30” Winner (2016), HSBC Young Entrepreneur Awards (Asia) winner (2011) and a Hong Kong Jockey Club Scholar (2007). Mr. Chen is an enthusiast in sports – he had played baseball for China and is now playing badminton for a leading club in China.